Expertise

Elaine is a Legal Director in the Product Safety & Disputes team. She specialises in complex product liability, mass tort and regulatory disputes, with a particular focus on the life sciences and consumer sectors. She acts for global manufacturers, corporate clients and government bodies on high-profile, multi-jurisdictional matters and is known for her clear, commercially focused approach to litigation and risk management.

Elaine has extensive experience in defending large-scale medical device and pharmaceutical litigation, as well as advising on product risk, recalls and regulatory strategy. She has particular experience in claims involving implantable and other healthcare products, including group and mass claims, large-scale recalls and cross-border disputes across the UK and EMEA. Her practice spans contentious and advisory work, from managing claims before the English courts and coordinating defence strategies across multiple jurisdictions, to engaging with regulators and supporting clients in response to government-led reviews in the UK and EU.

Alongside her core life sciences practice, Elaine advises on non-life science product disputes and broader product and supply-chain risks. Her experience includes advising on product safety framework reviews, insurance and commercial disputes, and emerging risk areas such as PFAS-related exposure. She also advises on matters of wider public significance, including work connected with compensation issues arising from the Post Office Horizon scandal.

Experience

Elaine's experience includes:  

  • Acting for manufacturers in multi-million-pound group and mass claims involving hip implants, transvaginal mesh and other gynaecological and implantable devices.
  • Acting in relation to one of the largest worldwide recalls of medical devices, involving several thousand claims.
  • Advising on broader product and supply-chain risks, including global reviews of product safety and compliance frameworks.
  • Advising the Department for Business and Trade in connection with compensation issues arising from the Post Office Horizon scandal. 
  • Advising on emerging product liability exposure, including PFAS-related risk
Publications
  • "How UK and EU Product Liability Reform is Reshaping Pharma Risk" April 2026, Sedgwick Recall Index
  • "Navigating the Evolving Pharmaceutical Landscape: A Review of 2023 and Outlook for 2024" January 2024, Sedgwick Recall Index
  • "Critical Medicines and Regulatory Shifts: What Lies Ahead" November 2024, Sedgwick Recall Index
  • "Navigating the green road ahead: The impact of the new EU battery regulation on the automotive industry" October 2023
  • "Food Products: Regulation and Risks", Product Liability Laws and Regulations 2022, International Comparative Legal Guide.
Education
  • Cardiff University (LPC, 2006)
  • Cardiff University (Law LLB, 2004